Celestica's AI Infrastructure Momentum Looks Undeniable, but Can Margins Hold Through the Expansion?

Barchart Part 2: Historical Earnings Performance

Celestica has demonstrated a strong track record of exceeding expectations, beating estimates in six of the last eight quarters. The magnitude of beats has been substantial: +15.60% in Q2 2025, +8.27% in Q3 2025, and +11.80% in Q4 2025. The company's only recent miss came last quarter (Q1 2026) at -1.52%, breaking a three-quarter winning streak.

The pattern reveals accelerating earnings power. Reported EPS has climbed from $1.26 in Q2 2025 to $1.44 in Q3 2025, $1.80 in Q4 2025, and $1.95 in Q1 2026 — a clear upward trajectory. However, the Q1 2026 miss, though modest, may signal that analyst estimates are finally catching up to reality after lagging the company's performance for most of 2025. With consensus now calling for $2.12 in Q2 2026, the bar has been raised considerably, and investors will be watching closely to see if CLS can clear it.

Quarter	EPS Estimate	EPS Actual	Surprise %	Beat/Miss
Jun 2025	$1.09	$1.26	+15.60%	Beat
Sep 2025	$1.33	$1.44	+8.27%	Beat
Dec 2025	$1.61	$1.80	+11.80%	Beat
Mar 2026	$1.98	$1.95	-1.52%	Miss

Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.

Part 2.1: Price Behavior Around Earnings

Celestica typically reports after market close, meaning Day 0 captures anticipatory moves before results are released, while Day +1 reflects the market's first full session to digest the actual numbers.

Earnings Date	Day 0 Move	Day 0 Range	Day +1 Move	Day +1 Range
2026-04-27	+$12.00 (+2.93%)	$23.24 (5.67%)	-$60.67 (-14.37%)	$42.69 (10.11%)
2026-01-28	+$12.06 (+3.62%)	$22.10 (6.63%)	-$45.23 (-13.10%)	$48.65 (14.09%)
2025-10-27	+$5.20 (+1.75%)	$12.60 (4.25%)	+$24.63 (+8.16%)	$40.94 (13.56%)
2025-07-28	+$3.15 (+1.85%)	$4.52 (2.66%)	+$28.63 (+16.51%)	$25.49 (14.71%)
2025-04-24	+$3.95 (+4.48%)	$5.12 (5.81%)	-$3.09 (-3.35%)	$6.07 (6.59%)
2025-01-29	+$6.01 (+6.36%)	$4.78 (5.06%)	+$13.66 (+13.59%)	$6.67 (6.64%)
2024-10-23	+$1.47 (+2.62%)	$2.41 (4.30%)	+$10.47 (+18.22%)	$5.84 (10.16%)
2024-07-24	-$4.49 (-7.76%)	$3.62 (6.25%)	-$2.32 (-4.35%)	$5.55 (10.40%)
Avg Abs Move	3.92%	5.08%	11.46%	10.78%

Historical price action around earnings reveals extreme volatility, particularly on Day +1. The average absolute Day +1 move is 11.46%, with individual reactions ranging from -14.37% (April 2026) to +18.22% (October 2024). The most recent earnings (April 2026) triggered a 14.37% decline the following day despite a modest +2.93% Day 0 move, suggesting the market was disappointed even though the company only missed by 1.52%.

The pattern shows Day 0 moves are relatively contained (averaging 3.92%), but Day +1 reactions are explosive and directionally unpredictable. Three of the last four reports saw Day +1 declines, including double-digit drops in January and April 2026, while earlier reports in 2024 and mid-2025 generated powerful rallies. Investors should brace for significant volatility — the stock has moved more than 10% the day after earnings in five of the last eight releases.

Part 2.2: Options Market Expected Move

Metric	Value
Expiration Date	07/31/26 (DTE 7)
Expected Move	$35.41 (11.58%)
Expected Range	$270.32 to $341.14
Implied Volatility	125.25%

The options market is pricing an 11.58% expected move through July 31 expiration, slightly above the historical average Day +1 move of 11.46% but well within the range of recent outcomes. Given that four of the last eight earnings triggered Day +1 moves exceeding 13%, the options market appears reasonably calibrated to CLS's post-earnings volatility profile.

Part 3: What Analysts Are Saying

Analysts remain overwhelmingly bullish on Celestica despite recent price weakness. The consensus rating stands at 4.84 out of 5.0 (Strong Buy territory), with 17 Strong Buys, 1 Moderate Buy, and just 1 Hold — no sell ratings whatsoever among the 19 analysts covering the stock. The average price target of $446.53 implies 46% upside from the current $305.28 price, with the high target of $510 suggesting some analysts see potential for a 67% rally.

Sentiment has improved over the past month, with Strong Buy ratings increasing from 16 to 17 and Hold ratings declining from 2 to 1. This upgrade activity suggests analysts are growing more confident in the company's growth trajectory even as the stock has pulled back. The wide target range — from $350 to $510 — reflects differing views on valuation multiples, but the clustering of bullish ratings indicates broad agreement that CLS's fundamental momentum remains intact. The disconnect between analyst enthusiasm and recent price action creates an intriguing setup heading into earnings.

Part 4: Technical Picture

Celestica's technical picture has deteriorated sharply heading into earnings, with the stock trading at $305.28 — below all major moving averages. The Barchart Technical Opinion has shifted dramatically from 56% Buy a month ago to 24% Sell currently, with last week's reading at 8% Sell showing the decline accelerated recently. This represents a significant reversal in momentum.

Timeframe Analysis:

• Short-term (50% Sell): Moderate sell signal indicates near-term pressure as the stock breaks down through support levels
• Medium-term (50% Buy): Conflicting buy signal suggests the intermediate trend may still be intact despite recent weakness
• Long-term (50% Sell): Moderate sell signal reflects deterioration in the longer-term uptrend that characterized most of 2025

Trend Characteristics: The Weak strength combined with Average direction suggests an indecisive, choppy environment where neither bulls nor bears have established clear control heading into this high-stakes earnings event.

The stock is trading below its 50-day moving average of $362.78 by nearly 16%, representing a significant technical breakdown from the uptrend that carried shares to higher levels earlier this year. The 200-day moving average at $325.01 sits just above the current price, providing potential resistance. Price is also below the 20-day ($338.33), 10-day ($325.26), and 5-day ($324.49) averages, confirming the recent selling pressure across all timeframes.

Period	Value	Period	Value
5-Day MA	$324.49	50-Day MA	$362.78
10-Day MA	$325.26	100-Day MA	$347.24
20-Day MA	$338.33	200-Day MA	$325.01

The technical setup is decidedly cautionary. With the stock in a clear downtrend across multiple timeframes and trading below all key moving averages, CLS faces earnings from a position of technical weakness. The 200-day moving average at $325.01 represents the nearest meaningful resistance level, while the breakdown below the 50-day suggests the path of least resistance may be lower if results disappoint. However, the extreme bearish positioning could also set up a powerful short-covering rally if the company delivers a strong beat and raises guidance — historical volatility suggests a 10%+ move in either direction is well within the realm of possibility.